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Abstract   
Erectile dysfunction  (ED) is a considerable  problem in  hemodialysis ( HD)  patients.   Many organic and 
psychological factors has been reported to take part in the pathophysiology of this condition. The aim of this 
study is to determine the  prevalence of sexual dysfunction among ( HD)  patients.  This  study included 147 
male patients on ( HD) therapy  We explained to them each of the questions  and asked them to complete an    
Arabic version of the IIEF questionnaire used   to determine the sexual problems and the prevalence of erectile 
dysfunction in male ( HD)  patients. The result shows that the mean age of ( HD)  patients was 54.73±14.08 
years (23–78), and the duration of ( HD)  was 16.03±15.66 months. By means of the IIEF, the prevalence of 
erectile dysfunction (ED)   was 86.6%. The prevalence and the severity of ED showed significant  increase as 
the age increased (p <0.05).  also diabetes  , ischemic heart  disease  artery disease and obesity were associated 
with increased prevalence and severity of ED. In conclusion we can say that Erectile dysfunction is highly 
prevalent in ( HD)  patients. The prevalence and the severity of ED increase with age. DIABETES, OBESITY 
AND ischemic heart  disease  Evaluations and efficient therapy for ED should be included  in routine 
assessment of ( HD)  patients. 
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1. Introduction  
Erectile dysfunction (ED) is the persistent inability to achieve and/ormaintains an erection for satisfactory 
sexual activity [1] Erectile dysfunction is a distressing problem in hemodialysis (HD) patients [2,3]. It’s an 
important cause of quality of life (QOL) limitation [4]. Combinations of organic and psychological factors have 
been reported to take part in the pathophysiology of this condition [2] Since the 1970s, when the first works on 
sexual function in uremic patients were published, several studies have highlighted the high prevalence of 
sexual dysfunction among patients   with chronic renal failure  (CRF)  [2]. The international index of erectile 
dysfunction [IIEF] was introduced in1997  [5]. The IIEF is a brief, reliable and valid self-administered 
questionnaire of 15 items. The IIEF has high sensitivity and specificity for evaluating the effects of treatment in 
patients with ED of different etiologies [6].  
2.  Aim of the Work  
The aim of this work was to study the prevalence of  ED in CRF patients on HD  and its correlation with other 
risk factors.      
3. Patients and Methods   
The present study was carried out on 147 chronic renal failure patients on HD  aged (40 to 65 years old ) who 
have regular sexual activities .  Patients with major organ affection   mental retardation or psychological 
abnormalities were excluded. Patients were recruited from  Fayoum general hospital  and  Fayoum university 
hospitals. All patients  were subjected to detailed history and thorough  medical examination .  All patients were 
asked to Complete a validated Arabic version of the   (IIEF5) questionnaire [7] and to complete a questionnaire 
scanning for other erectile dysfunction risk factors . The IIEF-5 scores were used to correlate the severity of ED 
to duration of HD therapy and associated diseases as benign prostatic hyperplasia (BPH ) diabetes mellitus 
(DM), hypertension (HTN) and cardiovascular diseases (CVS). Based on the IIEF-5 scores, The severities of 
ED were defined as follows: normal (no ED): 25-30, mild: 19-24, mild to moderate: 13-18, moderate: 7-12, and 
severe: 1-6 (according to IIEF-1997). [8]. A   blood sample was obtained to assess  Total testosterone, Prolactin, 
Thyroid stimulating hormone ( TSH)   the glycated hemoglubin (HbA1c ) if the patient is diabetic , creatinine , 
calcium, and hemoglobin.  
Statistical analysis: Data was coded and analyzed using the statistical package for social science ( SPSS 
version16) Data was summarized as mean, standard deviation and rang for quantitative variables and percent for 
qualitative variables. Comparison between groups was done using independent sample t-test, ANOVA (analysis 
of variants)  P-values < 0.05 were considered as statistically significant.  
4. Resuls 
 The present study was carried out on 147 CRF patients on HD   recruited from HD units of  Fayoum university  
hospital and  Fayoum general hospital .  The prevalence of ED according to IIEF5 score was 93.2 % for all HD  
subjects .  The mean  age of the patients was  52.96 ± 6.62 years   ( 35   -  62  years ). 
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Regarding  the grade ED  Based on the IIEF-5 scores, The severities of ED were defined as follows: normal (no 
ED): 25-30, mild: 19-24, mild to moderate: 13-18, moderate: 7-12, and severe: 1-6 (according to IIEF-1997). In 
this  study  it was found that 92.2 of the  patients  had ED while only 6.8% had no ED and the different grades 
of ED  are shown in fig.1  
 
Fig.1 – Different  of  ED in the study population 
ED =   erectile dysfunction  ,  NO ED = No erectile dysfunction 
In this  study  it was  noted that The  prevalence and severity of ED  increased with increased patient age  and  
the  results were statistically   significant  also there was a positive association  of smoking  history and duration  
with ED  and  there was no significant  association between the BM1 and ED  in HD patients of the present 
study ( Table 1 ) . 
Regarding the association of different diseases with ED  in the study population  77 out of 78 of diabetics (fig.-2 
), also78 out of 81 patients with Coronary insufficiency (fig.-3 ) and 88 out of 91 patients  with BPH  had ED (P 
value = < 0.001 , 0.008  and 0.006  ) ( Table 2 ).  
The  prevalence of ED among patients receiving  Erythropoietin less than two times per week for CRF induced 
anemia were found to have more  (110 out of 113) compared to patients receiving Erythropoietin twice weekly 
or  more (27 out of 34) and the difference was statistically significant (p=0.034) ( Table 2) .  No statistically 
significant association was noted as regards HTN heart Failure or the  duration of HD ( Table 2 )  . Seventeen 
patients had subclinical hypothyroidism , thirteen of them had ED with no significant association  with ED . 
Also , there was no significant association between prolactin or testosterone levels and ED in the study group ( 
Table 1 ) . 
 
216 
 
International Journal of Sciences: Basic and Applied Research (IJSBAR) (2014) Volume 17, No  2, pp 214-223 
Table 1  - Association of socio demographic data with ED in HD patients. 
Socio demographic data No  ED With ED P-value 
 
n % n % 
Age (years)      
< 50 7 70 22 16.7  
≥ 50 3 30 115 84.3 < 0.001 
Body mass index      
< 25 5 50 63 45  
≥ 25 5 50 75 55 0.844 
History of current or previous smoking      
No 2 20 11 9  
Yes 8 80 126 91 0.016 
Years of smoking (smoking or smoked)      
< 20 3 30 17 13  
≥ 20 7 70 120 87 0.003 
*ED = Erectile Dysfunction; 
 
 
Fig.2- The association of diabetes and ED 
ED = erectile dysfunction ,  NO ED = No erectile dysfunction 
DM = diabetes Mellitus 
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Table 2  - Association of clinical data with ED in HD patients 
Clinical data No ED With ED P-value 
 
n n 
Diabetes Mellitus 
      No 9 60 
Yes 1 77 < 0.001 
Hypertension  
No 2 56  
Yes 8 81 0.088 
Coronary insufficiency  
No 6 59  
Yes 4 78 0.008 
heart failure  
No 6 77  
Yes 4 60 0.334 
BPH  
No 7 49  
Yes 3 88 0.006 
Duration of HD (months)  
< 48 5 66  
≥ 48 5 71 0.244 
Erythropoietin therapy  
≥  twice per week 7 27  
<  twice per week 3 110 0.034 
Hyperptolactinemia  
No 6 121  
Yes 4 16 0.344 
Hypothyroidism  
No 7 123  
Yes 3 14 0.584 
Abnormal testosterone  
No 6 126  
      Yes 4 11 0.436 
                              
ED = Erectile Dysfunction; HD = hemodialysis; 
BPH = Benign prostatic hyperplasia 
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Table 3  - Association of  The cause of CRF with ED in HD patients. 
Cause of CRF Without ED With ED P-value 
 
n n 
Medication abuse  
No 6  131  
Yes 2 6 0.877 
Diabetes Mellitus  
No 9  60  
Yes 1 77 < 0.001 
Glomerulonephritis  
No 3  125  
Yes 7 12 0.011 
Hypertension  
No 2  56  
Yes 8 81 0.088 
Polycystic disease  
No 8  133  
Yes 2 4 0.975 
Unknown  
No 8  121  
Yes 2 16 0.597 
            Total 10 137  
CRF = Chronic renal failure ED = Erectile Dysfunction; HD = hemodialysis; 
As regard the etiological cause  of CRF  and  association  with ED in HD patients in this study  it was found that 
72 patients had DM, 19 had Glomerulonephritis , 99 had HTN , 6 had polycystic kidney , 8 had a history of  
drug abuse and 18 patients the etiology of CRF  was unknown.  Diabetes and Glomerulonephritis showed 
significant association with ED   in this  study (p =0.001  and 0.011) (Table 3). 
5. Discussion 
Erectile dysfunction (ED) has a higher  prevalence in patients treated for chronic renal insufficiency  and  
significantly impairing their quality of life [9] . In men with    CRF  the etiology of ED is often multifactorial ; 
uremia, medications, associated co-morbid conditions, physiologic changes with dialysis and the causative 
pathophysiology leading to the patient’s chronic renal failure should all be considered prior to initiating HD  
[10]. The prevalence of ED in patients on HD   in our study was 93.2%. In previous studies   conducted by  [11, 
12, 13, 1 , 9]  the prevalence   ranged from 41.5 to 86.4%  . 
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Fig.3  The association of IHD and ED 
IHD=Ischemic heart  disease   , ED = erectile dysfunction 
NO= No Ischemic heart  disease ,  NO ED = No erectile dysfunction 
 
In the present study there was a significant correlation  between the patient age  and the prevalence of ED ( 
Table 1) as 16.4 %,  of  subjects younger than 50 years had  ED   while 83.6 % of subjects aged 50 years or 
more were found to have ED. (p<0.05). Many previous studies  were in agreement with our results    for 
example  studies conducted by [12, 1, 6, 13]    
In the present study there was no significant correlation between BMI and different grades of ED  ( Table 1)  
and  this agree with results concluded by [13].  Who found that  most  of patients who have moderate to severe 
grades of ED were  overweight and only   25 % of patients who have  mild to moderate   grades of ED were  
obese . 
   In our study   the mean duration of HD was 58 months (9 months to 15 years ) and there was no significant 
association between the  duration of HD  and the prevalence of ED( Table 2) . This finding is similar to previous 
studies by [14, 1, 6]. 
In the current study there was  statistically significant association between  smoking and its duration and the 
prevalence of ED ( Table 1).   This finding  is not  consistent with  [12, 6, 13 , 15] and is consistent with [14] 
who reported a significant correlation between smoking  and ED. 
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 In this  study  Hypertension  was found in 67 % of the study population, but no significant association was 
detected between HTN  and ED ( Table 2) and this is consistent with the results of a  study conducted by [13]. 
Also, some anti-hypertensive medications was claimed to worsen sexual function due to their direct effects on 
the vascular system.  In this study there was no significant association   detected between antihypertensive  
medications and ED. This differs from the results of [16] who reported that beta  blockers demonstrated the 
most negative effects on sexual function in HD  patients, while vasodilators increased genital blood flow, hence, 
alleviated the problem.  
 Regarding   DM  the presence of DM in our patients was 53%.  nearly all (77 out of 78)  of them had ED, there 
was a  statistically significant association between DM and  ED . Prior studies have repeatedly shown a high 
prevalence and a significant association of ED with diabetes like  [6]) who reported that DM is an independent 
risk factor for  ED in  HD patients and  [13] who also found a strong association.  In our study there were no 
statistically significant correlation between ED   and dyslipidemia  and  this  is  similar to the findings of  [17] . 
On the other hand  [14] found a statistically significance correlation between dyslipidemia  and ED. 
 Based on the high prevalence of ED with hypertension, hyperlipidemia, diabetes mellitus and depression, [18] 
proposed that ED should be used as a marker for these concurrent diseases, and that ED should be given the 
deserved attention in the assessment profile for these diseases.  
In this  study testosterone level was lower than normal in 6 patients and higher than normal in 9  patients. 
Prolactin level was higher than normal in 20 patients , however the correlation between both of them and ED 
was statistically insignificant  . Also 17 patients  had subclinical hypothyroidism   but  there was no statistically 
significant correlation between TSH  level and ED.  
6. Study Limitations   
Factors  that limit our findings.  The sample size   was relatively small, so this limits the possibility of detecting 
some interactions such as ED and obesity or hypertension. Being a cross-sectional study, so it is just possible to 
find an association links between ED and risk factors without certainty of a causal relation between them. Also 
this study did not assess variables that have been linked to ED, such as autonomic neuropathy, peripheral 
vascular disease, residual renal functions And lastly data of those patients were collected from only 2 centers 
and if more centers were included the results may be more representative of all urban and rural population. 
7. Conclusion:  
Erectile dysfunction is highly prevalent in ( HD)  patients. The prevalence and the severity of ED increase with 
age. DIABETES, OBESITY AND ischemic heart  disease  Evaluations and efficient therapy for ED should be 
included  in routine assessment of ( HD)  patients.  
8. Recommendations  
Physicians in the HD units   who should be aware of patients’ unexpressed expectations and should enhance the 
disclosure of patients’ erectile problems. Thus, patients would not feel embarrassed while touching  this problem 
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with their physicians. In this respect, the IIEF is a valuable method of unveiling the erectile problems of HD 
patients. The IIEF is a practicable and self administered questionnaire that can explore this very intimate 
problem and provide highly informative results. The routine use of IIEF for the diagnosis and treatment of ED 
should be considered in this group of patients.   Also   factors associated with increased risk of developing ED in 
CRF patients  like DM , IHD and smoking should be addressed and controlled  
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